Drug Shortage Report for REMIFENTANIL HYDROCHLORIDE FOR INJECTION

Last updated on 2021-11-25 History
Report ID 149457
Drug Identification Number 02366460
Brand name REMIFENTANIL HYDROCHLORIDE FOR INJECTION
Common or Proper name REMIFENTANIL HYDROCHLORIDE FOR INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) REMIFENTANIL
Strength(s) 1MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS
ATC code N01AH
ATC description ANESTHETICS, GENERAL
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2021-11-16
Estimated end date 2021-11-26
Actual end date 2021-11-24
Shortage status Resolved
Updated date 2021-11-25
Company comments SteriMax regrets to inform that there has been an administrative release delay for Remifentanil 1 mg and we are currently encountering a supply interruption. We anticipate this being resolved by Friday November 26th.
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-11-16 English Compare
v2 2021-11-16 English Compare
v3 2021-11-16 French Compare
v4 2021-11-17 English Compare
v5 2021-11-24 English Compare
v6 2021-11-24 French Compare
v7 2021-11-25 English Compare